Russian scientists says EpiVacCorona effective against variants
Russia began mass trials of EpiVacCorona, which is being developed by Siberia's Vector Institute, in November last year
The World Health Organization says pregnant women can be badly affected by some respiratory infections, and that it is not known whether mothers with Covid-19 can pass the virus to their babies during pregnancy or delivery Photo: Reuters
Russian scientists behind the country's second vaccine against Covid-19, EpiVacCorona, said on Monday the shot was effective against variants of the coronavirus.
Russia began mass trials of EpiVacCorona, which is being developed by Siberia's Vector Institute, in November last year.
Keep updated, follow The Business Standard's Google news channel
